Dongliang Zhuang Selected Research

CKD732

1/2018	Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial.
12/2017	Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dongliang Zhuang Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 01/2018 - 05/2005
4	Weight Loss (Weight Reduction) 01/2018 - 05/2005
2	Pulmonary Embolism 01/2018 - 12/2017
2	Obesity 01/2018 - 12/2017
1	Headache (Headaches) 01/2018
1	Venous Thromboembolism 01/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2017
1	Hyperphagia (Overeating) 12/2017
1	Hyperglycemia 06/2007
1	Body Weight (Weight, Body) 06/2007
1	Weight Gain 05/2005

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 06/2007
3	Exenatide (Byetta)FDA Link 10/2008 - 05/2005
2	methionine aminopeptidase 2IBA 01/2018 - 01/2018
2	CKD732IBA 01/2018 - 12/2017
2	IncretinsIBA 10/2008 - 05/2005
2	Metformin (Glucophage)FDA LinkGeneric 06/2007 - 05/2005
1	ZGN-1061IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2008

Therapy/Procedure

2	Glycemic Control 06/2007 - 05/2005
1	Therapeutics 05/2005